Skip to Content

New Drug Approvals Archive - December 2011

See also: New Indications and Dosage Forms for December 2011

December 2011

Anturol (oxybutynin) Gel

Date of Approval: December 7, 2011
Company: Antares Pharma, Inc.
Treatment for: Overactive Bladder

Anturol (oxybutynin) is an anticholinergic transdermal gel formulation indicated for the management of overactive bladder.

Edarbyclor (azilsartan medoxomil and chlorthalidone) Tablets

Date of Approval: December 20, 2011
Company: Takeda Pharmaceutical Company Limited
Treatment for: Hypertension

Edarbyclor (azilsartan medoxomil and chlorthalidone) is a fixed-dose combination of an angiotensin II receptor blocker (ARB) and a diuretic, indicated for the treatment of hypertension.

New Drug Approvals Archive

2019January, February

2018January, February, March, April, May, June, July, August, September, October, November, December

2017January, February, March, April, May, June, July, August, September, October, November, December

2016January, February, March, April, May, June, July, August, September, October, November, December

2015January, February, March, April, May, June, July, August, September, October, November, December

2014January, February, March, April, May, June, July, August, September, October, November, December

2013January, February, March, April, May, June, July, August, September, October, November, December

2012January, February, March, April, May, June, July, August, September, October, November, December

2011January, February, March, April, May, June, July, August, October, November, December

2010January, February, March, April, May, June, July, August, September, October, November, December

2009January, February, March, April, May, June, July, August, September, October, November, December

2008January, February, March, April, May, June, July, August, September, October, November, December

2007January, February, March, April, May, June, July, August, September, October, November, December

2006January, February, March, April, May, June, July, August, September, October, November, December

2005January, February, March, April, May, June, July, August, September, October, November, December

2004January, February, March, April, May, June, July, August, September, October, November, December

2003January, February, March, April, May, June, July, August, September, October, November, December

2002January, February, April, May, July, August, October, November, December

More News Resources

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Recently Approved

Egaten Egaten (triclabendazole) is a benzimidazole anthelmintic indicated for the...
Cablivi Cablivi (caplacizumab-yhdp) is a von Willebrand factor (vWF)-directed antibody...
Jeuveau Jeuveau (prabotulinumtoxinA) is a proprietary 900 kDa purified botulinum toxin...
Wixela Inhub Wixela Inhub (fluticasone propionate and salmeterol) is a corticosteroid and...

Get Email Updates

Subscribe to free Drugs.com newsletters.

By clicking Subscribe, I agree to the Drugs.com Terms & Conditions and Privacy Policy and understand that I may opt out of Drugs.com subscriptions at any time.

Drugs.com Pill Reminder

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include IBM Watson Micromedex (updated 9 Jan 2019), Cerner Multum™ (updated 14 Jan 2019), Wolters Kluwer™ (updated 7 Jan 2019) and others. Refer to our editorial policy for content sources and attributions.